it is concluded that , because of its greater effect on blood glucose and hdl cholesterol , the combination of bezafibrate with glibenclamide would appear to be the best of the regimens studied for the treatment of non-insulin-dependent diabetics with associated hyperlipoproteinaemia .
C0017628
glibenclamide
C0011860
non-insulin-dependent diabetics